Cold Plasma in Healthcare Market to Grow with a CAGR of 12.14% through 2028
Rising healthcare awareness and increasing chronic diseases is driving
the growth of Cold Plasma in Healthcare market in the forecast period
2024-2028.
According to TechSci Research report, “Cold Plasma in Healthcare
Market – Global Industry Size, Share, Trends, Competition Forecast &
Opportunities, 2028”, the Global Cold Plasma in Healthcare Market
stood at USD 1.89 billion in 2022 and is anticipated to grow with a CAGR of 12.14%
in the forecast period, 2024-2028. The global Cold Plasma in Healthcare Market
has witnessed significant growth in recent years, driven by various factors
that have reshaped the healthcare landscape. Cold plasma, also known as
non-thermal or atmospheric pressure plasma, is a novel technology that has
garnered attention for its potential applications in various medical fields.
This innovative approach employs ionized gases to produce a cold plasma state,
which can be utilized for sterilization, wound healing, cancer treatment, and
more.
One of the primary
drivers of the cold plasma in healthcare market is its remarkable sterilization
capabilities. With the increasing concern over hospital-acquired infections
(HAIs) and antibiotic-resistant bacteria, the demand for efficient and non-toxic
sterilization methods has surged. Cold plasma technology provides a
chemical-free and effective solution to decontaminate medical equipment,
surfaces, and even the air within healthcare facilities. This not only ensures
patient safety but also reduces healthcare-associated costs, a critical
consideration for hospitals and clinics.
Moreover, the
ability of cold plasma to promote wound healing and tissue regeneration has
made it a valuable asset in healthcare. Chronic wounds, such as diabetic
ulcers, are a growing concern globally. Cold plasma can accelerate the healing
process by stimulating cell proliferation and angiogenesis while minimizing
infection risk. This has led to increased adoption of cold plasma devices in
wound care and regenerative medicine. However, despite its
promising applications, the cold plasma in healthcare market faces several
challenges. First and foremost is the need for rigorous testing and regulatory
approvals. Healthcare authorities worldwide require robust scientific evidence to
support the safety and efficacy of cold plasma devices. Achieving regulatory
clearance can be time-consuming and costly, which may deter some manufacturers
from entering the market. Another challenge is
the limited awareness and understanding of cold plasma technology among
healthcare professionals. Training and education are essential to ensure that
medical practitioners can harness the full potential of this technology.
Moreover, integrating cold plasma devices into existing healthcare workflows
can be a complex process, requiring investment in infrastructure and staff
training.
The COVID-19
pandemic has had a significant impact on the cold plasma in healthcare market.
On one hand, the need for rapid and effective sterilization methods in
healthcare facilities increased during the pandemic. Cold plasma's ability to
quickly decontaminate surfaces and equipment became highly relevant. However,
the pandemic also disrupted supply chains and slowed down regulatory processes,
affecting the market's growth trajectory.
Looking ahead,
several trends are expected to shape the future of the cold plasma in
healthcare market. One such trend is the increasing adoption of cold plasma in
cancer treatment. Cold plasma has shown promise in selectively targeting and
killing cancer cells while sparing healthy tissue, making it a potential
alternative to traditional cancer therapies like radiation and chemotherapy. Additionally, the
development of portable and handheld cold plasma devices is expected to expand
the market's reach beyond hospitals and clinics. These devices can be used in
home healthcare settings, further increasing their accessibility and versatility.
Browse over XX market data Figures spread through XX Pages and an
in-depth TOC on
"Global Cold Plasma in Healthcare Market"
The Global Cold
Plasma in Healthcare Market is segmented into application, regional
distribution, and company
Based on application,
the wound healing segment has emerged as the predominant market leader in the Cold
Plasma in Healthcare market. The wound healing segment has emerged as the
predominant market leader in the Cold Plasma in Healthcare market due to its
compelling and transformative applications in the field of wound care and
tissue regeneration. Cold plasma technology has demonstrated remarkable
efficacy in accelerating the healing process of chronic and acute wounds, which
has garnered significant attention from healthcare providers and researchers
alike. One of the key factors driving the dominance of the wound healing
segment is the pressing global issue of chronic wounds. Conditions like
diabetic ulcers and pressure sores pose a substantial healthcare burden,
leading to prolonged patient suffering, increased healthcare costs, and a
higher risk of complications. Traditional wound care methods often fall short
in addressing these challenges, leading to a growing demand for innovative
solutions. Cold plasma's ability to stimulate cell proliferation, angiogenesis,
and tissue regeneration has shown tremendous promise in expediting wound
closure and reducing the risk of infection. By creating a conducive environment
for the body's natural healing processes, cold plasma technology has the
potential to revolutionize wound care practices. Furthermore, the non-invasive
and non-thermal nature of cold plasma treatment sets it apart from other wound
care modalities. Patients and healthcare providers appreciate that cold plasma
therapy is gentle on tissues, minimizing pain and discomfort during treatment.
This makes it an attractive option for individuals with sensitive wounds or
those who are unable to undergo more aggressive therapies. The COVID-19
pandemic also played a role in emphasizing the significance of cold plasma in
wound healing. Hospitals and healthcare facilities faced unprecedented
challenges during the pandemic, including the need to manage patients with
severe respiratory conditions who were prone to pressure sores. Cold plasma
technology's ability to aid in wound healing while maintaining a sterile
environment became increasingly vital during this time.
Based on region, North
America region anticipated to experience significant growth during the forecast
period in the Cold Plasma in Healthcare market. The North America region is
anticipated to experience significant growth during the forecast period in the
Cold Plasma in Healthcare market for several compelling reasons. This
geographical area, which includes the United States and Canada, is poised to be
a key driver in the expansion of the cold plasma healthcare market. One of the
primary factors contributing to North America's growth in this sector is its
robust healthcare infrastructure and advanced medical research capabilities.
The region boasts a plethora of top-tier medical institutions, research
centers, and pharmaceutical companies that are at the forefront of adopting
cutting-edge technologies, including cold plasma, in their medical practices
and research endeavors. This strong foundation for research and innovation
creates a conducive environment for the development and adoption of cold plasma
applications in healthcare. Moreover, North America has a high prevalence of
chronic diseases and conditions that require innovative and efficient medical
treatments, such as diabetic ulcers, cancer, and skin disorders. Cold plasma
technology's versatility in wound healing, cancer treatment, and dermatology
applications aligns perfectly with the region's healthcare needs, driving its
increasing adoption. Another driving factor is the presence of a favorable
regulatory environment for medical devices and technologies in North America.
The rigorous but well-defined regulatory pathways for market approval and
patient safety instill confidence in both manufacturers and healthcare
providers, encouraging the development and adoption of cold plasma-based
healthcare solutions. Furthermore, the increasing awareness of patient safety
and infection control, especially in the wake of the COVID-19 pandemic, has led
to a surge in demand for sterilization and disinfection technologies. Cold
plasma's ability to effectively decontaminate surfaces and equipment without
the use of harmful chemicals positions it as an asset in healthcare facilities,
further fueling its growth in the region. Additionally, collaborations between
academia, industry, and healthcare providers are fostering innovation and
knowledge sharing, which is essential for the successful integration of
emerging technologies like cold plasma into mainstream healthcare practices.
Major companies operating in Global Cold Plasma in Healthcare Market
are:
- Neoplas
med GmbH
- U.S.
Medical Innovations
- Terumo
Medical Corp
- Adtec
Plasma Technology Co Ltd
- Apyx
Medical Corp
- Nordson Corp
- Europlasma NV
- Terraplasma GmbH
- Henniker Plasma
- Smith & Nephew plc
Download Free Sample Report
Customers can also request for 10% free customization on this report
“The Cold Plasma in Healthcare market is witnessing robust growth, with
several leading companies at the forefront of technological advancements.
Companies such as Nordson Corporation, Adtec Plasma Technology Co., Ltd., and
Terraplasma Medical GmbH are spearheading innovation in cold plasma
applications for healthcare. These companies are investing heavily in research
and development to refine and expand the use of cold plasma in sterilization,
wound healing, cancer treatment, and more. Technological advancements include
the development of portable and handheld cold plasma devices, which enhance
accessibility and usability in various healthcare settings. With ongoing
collaborations between academia and industry, we can expect continued
breakthroughs that will further solidify cold plasma's position as a
transformative technology in the healthcare sector.” said Mr. Karan Chechi,
Research Director with TechSci Research, a research-based management consulting
firm.
“Cold Plasma in Healthcare
Market - Global Industry Size, Share, Trends, Opportunity, and Forecast,
2018-2028 Segmented By Application (Wound Healing, Surgical Application and
Other Medical Applications), By Region and Competition”, has evaluated the future growth potential
of Global Cold Plasma in Healthcare Market and provides statistics &
information on market size, structure and future market growth. The report
intends to provide cutting-edge market intelligence and help decision makers
take sound investment decisions. Besides, the report also identifies and
analyzes the emerging trends along with essential drivers, challenges, and
opportunities in Global Cold Plasma in Healthcare Market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]
Website: https://www.techsciresearch.com